Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients

Journal of Addictive Diseases

Volumn 26, Issue 1, 2007, Pages 15-26

  Adelson, Miriam ^a,b,c   Peles, Einat ^a   Bodner, Gershon ^a   Kreek, Mary Jeanne ^c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Dr Miriam and Sheldon G Adelson Clinic for Drug Abuse Treatment and Research   (Israel)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Methadone dose; Methadone maintenance treatment; Serum methadone

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; RECOMMENDED DRUG DOSE; STATISTICAL ANALYSIS; URINALYSIS;

ADULT; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PRESCRIPTIONS, DRUG; SUBSTANCE ABUSE DETECTION;

EID: 34249098369     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v26n01_03     Document Type: Article

References (27)

1. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966; 118:304-9.
2. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade: a medical technique for stopping heroin use by addicts. Transactions of the Association of American Physicians. 1966; 79:122-36.
3. Kreek MJ. Plasma and urine levels of methadone. NY State J Med. 1973; 73:2773-7.
4. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs. high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999; 281:1000-5.
5. Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. 2002; 161:202-12.
6. U.S. Federal Register 21 CRF Part 291 and 42 CRF Part 8 (1-17-2001) Opioid Drug in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule.
7. U.S. Drug Enforcement Administration Congressional Testimony at: www.dea.gov (Dec, 2004).
8. Eap CB, Bourquin M, Martin J, Spagnoli J, Livoti S, Powell K, Baumann P, Deglon J. Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment. Drug Alcohol Depend. 2000; 61:47-54.
9. Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. Journal of Maintenance in the Addictions. 2000; 1:5-13.
10. Hawks RL. Analytical methodology. NIDA Res Monogr. 1986; 73:30-42.
11. Loimer N, Schmid R. The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend. 1992; 30:241-6.
12. Bell J, Bowron P, Lewis J, Batey R. Serum levels of methadone in maintenance clients who persist in illicit drug use. Br J Addict. 1990; 85:1599-602.
13. Charlier C, Dessalles MC, Plomteux G. Methadone maintenance treatment: is it possible to adapt the daily doses to the metabolic activity of the patient? Ther Drug Monit. 2001; 23:1-3.
14. Wolff K, Sanderson M, Hay AW, Raistrick D. Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem. 1991; 37:205-9.
15. Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: use of higher dose of methadone. J Psychoactive Drugs. 1999; 31:95-102.
16. Maxwell S, Shinderman M. Optimizing longterm response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone. J Addict Dis. 2002; 21:1-12.
17. Kreek MJ, Gutjahr CL, Garfield JW, Bowen DV, Field FH. Drug interactions with methadone. Ann NY Acad Sci. 1976; 281:350-71.
18. Inturrisi CE, Verebely K. The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther. 1972; 13:633-7.
19. Inturrisi CE, Verebely K. A gas-liquid chromatographic method for the quantitative determination of methadone in human plasma and urine. J Chromatogr. 1972; 65:361-9.
20. Kreek MJ, Oratz M, Rothschild MA. Hepatic extraction of long- and short-acting narcotics in the isolated perfused rabbit liver. Gastroenterology. 1978; 75:88-94.
21. Kreek MJ, Hachey DL, Klein PD. Stereoselective disposition of methadone in man. Life Sci. 1979; 24:925-32.
22. 8 methadone. J Pharm Sci. 1982; 71:39-43.
23. Novick DM, Kreek MJ, Arns PA, Lau LL, Yancovitz SR, Gelb, AM. Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients. Alcohol Clin Exp Res. 1985; 9:349-54.
24. Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002; 41:1153-93.
25. Shinderman M, Maxwell S, Brawand-Amey M, Golay KP, Baumann P, Eap CB. Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses. Drug Alcohol Depend. 2003; 69:205-11.
26. Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA. Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther. 1984; 36:534-41.
27. Preston KL, Griffiths RR, Cone EJ, Darwin WD, Gorodetzky CW. Diazepam and methadone blood levels following concurrent administration of diazepam and methadone. Drug Alcohol Depend 1986; 18:195-202.